Clinical Trial Update: A Study of NTRX-07 in Participants With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NTRX-07 in Alzheimer's disease and mild cognitive impairment; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• NTRX-07

Snippet

Sponsor: NeuroTherapia, Inc. | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Status: RECRUITING